0001140361-17-007278.txt : 20170214
0001140361-17-007278.hdr.sgml : 20170214
20170214161845
ACCESSION NUMBER: 0001140361-17-007278
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170214
DATE AS OF CHANGE: 20170214
EFFECTIVENESS DATE: 20170214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
IRS NUMBER: 900924432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15935
FILM NUMBER: 17609169
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001577524
XXXXXXXX
12-31-2016
12-31-2016
Sarissa Capital Management LP
660 STEAMBOAT ROAD
GREENWICH
CT
06830
13F HOLDINGS REPORT
028-15935
N
Alexander J. Denner, Ph.D.
Chief Investment Officer
203-302-2330
/s/ Alexander J. Denner
Greenwich
CT
02-14-2017
0
11
363082
false
INFORMATION TABLE
2
form13fInfoTable.xml
ABBVIE INC.
COM
00287Y109
626
10000
SH
SOLE
10000
0
0
ADVAXIS INC
COM NEW
007624208
3579
500000
SH
SOLE
500000
0
0
APRICUS BIOSCIENCES INC
COM NEW
03832V307
1882
1447906
SH
SOLE
1447906
0
0
ARIAD PHARMACEUTICALS INC
COM
04033A100
159853
12850000
SH
SOLE
12850000
0
0
AVEO PHARMACEUTICALS INC
COM
053588109
917
1700000
SH
SOLE
1700000
0
0
BIOGEN INC
COM
09062X103
87909
310000
SH
SOLE
310000
0
0
INNOVIVA INC
COM
45781M101
31832
2975000
SH
SOLE
2975000
0
0
INTRA CELLULAR THERAPIES INC
COM
46116X101
5432
360000
SH
SOLE
360000
0
0
MEDICINES CO
COM
584688105
59462
1752000
SH
SOLE
1752000
0
0
NOVELION THERAPEUTICS INC
COM NEW
67001K202
8630
1025000
SH
SOLE
1025000
0
0
VIVUS INC
COM
928551100
2960
2573943
SH
SOLE
2573943
0
0